Respiratory infection in an immunocompromised person: Difference between revisions
From IDWiki
(Created page with "== Differential Diagnosis == === By Defect === {| class="wikitable" !Risk Factor !Differential Diagnosis !Investigations |- ! colspan="3" |Cell-Mediated Immunodeficiency |- |...") |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | == |
+ | ==Differential Diagnosis== |
− | === |
+ | ===By Defect=== |
{| class="wikitable" |
{| class="wikitable" |
||
!Risk Factor |
!Risk Factor |
||
Line 10: | Line 10: | ||
|- |
|- |
||
|Steroids and solid organ transplantation |
|Steroids and solid organ transplantation |
||
− | | rowspan=" |
+ | | rowspan="4" |opportunistic infections, systemic viruses, [[Pneumocystis]], [[Cryptococcus]], [[Mycobacteria]], [[Toxoplasma]] |
− | | rowspan=" |
+ | | rowspan="4" |sputum and blood culture, antigenuria, multiplex viral PCR, [[CMV]]/[[HSV]]/[[VZV]] PCR, bronchoalveolar lavage, [[Toxoplasma]]/[[Cryptococcus]] PCR, induced sputum, beta-D glucan |
|- |
|- |
||
− | |Hairy cell leukemia, acute T-cell leukemia, T-cell lymphoma |
+ | |[[Hairy cell leukemia]], [[acute T-cell leukemia]], [[T-cell lymphoma]] |
|- |
|- |
||
− | |Fludarabine, ibrutinib, alemtuzumab |
+ | |[[Fludarabine]], [[ibrutinib]], [[alemtuzumab]] |
+ | |- |
||
+ | |[[HIV]] |
||
|- |
|- |
||
! colspan="3" |Humoural Immunodeficiency |
! colspan="3" |Humoural Immunodeficiency |
||
Line 25: | Line 27: | ||
|Complement deficiency |
|Complement deficiency |
||
|- |
|- |
||
− | |Common variable immunodeficiency |
+ | |[[Common variable immunodeficiency]] |
|- |
|- |
||
− | |Rituximab and other anti-CD20 therapy |
+ | |[[Rituximab]] and other anti-CD20 therapy |
|- |
|- |
||
− | |Multiple myeloma and CLL |
+ | |[[Multiple myeloma]] and [[CLL]] |
|- |
|- |
||
! colspan="3" |Phagocyte Defects |
! colspan="3" |Phagocyte Defects |
||
Line 35: | Line 37: | ||
|Steroids and solid organ transplantation |
|Steroids and solid organ transplantation |
||
| rowspan="5" |systemic viruses, [[Aspergillus]], [[Mycobacteria]], [[Nocardia]], [[Mucorales]], [[Toxoplasma]] |
| rowspan="5" |systemic viruses, [[Aspergillus]], [[Mycobacteria]], [[Nocardia]], [[Mucorales]], [[Toxoplasma]] |
||
− | | rowspan="5" |sputum and blood cultures, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, induced sputum, bronchoalveolar lavage, fungal culture of sputum, [[β-D glucan]] and [[galactomannan]], Aspergillus PCR, Toxoplasma/Cryptococcus PCR |
+ | | rowspan="5" |sputum and blood cultures, antigenuria, multiplex viral PCR, [[CMV]]/[[HSV]]/[[VZV]] PCR, induced sputum, bronchoalveolar lavage, fungal culture of sputum, [[β-D glucan]] and [[galactomannan]], Aspergillus PCR, Toxoplasma/Cryptococcus PCR |
|- |
|- |
||
− | |Neutropenia |
+ | |[[Neutropenia]] |
|- |
|- |
||
− | |Myelodysplastic syndrome |
+ | |[[Myelodysplastic syndrome]] |
|- |
|- |
||
− | |Acute myelogenous leukemia |
+ | |[[Acute myelogenous leukemia]] |
|- |
|- |
||
− | |Allogeneic hematopoietic stem cell transplantation |
+ | |[[Allogeneic hematopoietic stem cell transplantation]] |
|} |
|} |
||
− | === |
+ | ===By CT Pattern=== |
{| class="wikitable" |
{| class="wikitable" |
||
!Pattern |
!Pattern |
||
Line 54: | Line 56: | ||
|nodular lesions |
|nodular lesions |
||
|bacterial pneumonia, [[Aspergillus]], [[Nocardia]], [[Mucorales]] |
|bacterial pneumonia, [[Aspergillus]], [[Nocardia]], [[Mucorales]] |
||
− | |sputum and blood cultures, antigenuria, sputum with fungal culture, Aspergillus/Mucorales PCR, [[galactomannan]] and [[β-D glucan]], bronchoalveolar lavage |
+ | |sputum and blood cultures, antigenuria, sputum with fungal culture, [[Aspergillus]]/[[Mucorales]] PCR, [[galactomannan]] and [[β-D glucan]], bronchoalveolar lavage |
|- |
|- |
||
|septal thickening |
|septal thickening |
||
Line 62: | Line 64: | ||
|cavitations |
|cavitations |
||
|[[Mycobacteria]], [[Histoplasma]], bacterial pneumonia including [[Staphylococcus aureus]] |
|[[Mycobacteria]], [[Histoplasma]], bacterial pneumonia including [[Staphylococcus aureus]] |
||
− | |sputum and blood cultures, mycobacterial culture, Histoplasma PCR |
+ | |sputum and blood cultures, mycobacterial culture, [[Histoplasma]] PCR |
|- |
|- |
||
|excavated nodules |
|excavated nodules |
||
|bacterial pneumonia, [[Mucorales]], [[Nocardia]], [[Actinomyces]], [[Aspergillus]] |
|bacterial pneumonia, [[Mucorales]], [[Nocardia]], [[Actinomyces]], [[Aspergillus]] |
||
− | |sputum and blood cultures, Aspergillus/Nocardia/Mucorales PCR, [[galactomannan]] and [[β-D glucan]] |
+ | |sputum and blood cultures, [[Aspergillus]]/[[Nocardia]]/[[Mucorales]] PCR, [[galactomannan]] and [[β-D glucan]] |
|- |
|- |
||
|consolidation |
|consolidation |
||
Line 78: | Line 80: | ||
|ground glass opacities |
|ground glass opacities |
||
|[[Pneumocystis]], viral pneumonia, atypical bacterial pneumonia |
|[[Pneumocystis]], viral pneumonia, atypical bacterial pneumonia |
||
− | |sputum and blood culture, Legionella antigenuria, sputum for Pneumocystis, β-D glucan, multiplex viral PCR, CMV/VZV/HSV blood PCR, bronchoalveolar lavage |
+ | |sputum and blood culture, [[Legionella]] antigenuria, sputum for [[Pneumocystis]], β-D glucan, multiplex viral PCR, [[CMV]]/[[VZV]]/[[HSV]] blood PCR, bronchoalveolar lavage |
|} |
|} |
||
− | == |
+ | ==Further Reading== |
− | * |
+ | *Diagnosis of severe respiratory infections in immunocompromised patients. ''Intensive Care Med''. 2020;46:298-314. doi: [https://doi.org/10.1007/s00134-019-05906-5 10.1007/s00134-019-05906-5] |
[[Category:Immunocompromised hosts]] |
[[Category:Immunocompromised hosts]] |
Latest revision as of 13:40, 10 March 2022
Differential Diagnosis
By Defect
Risk Factor | Differential Diagnosis | Investigations |
---|---|---|
Cell-Mediated Immunodeficiency | ||
Steroids and solid organ transplantation | opportunistic infections, systemic viruses, Pneumocystis, Cryptococcus, Mycobacteria, Toxoplasma | sputum and blood culture, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, bronchoalveolar lavage, Toxoplasma/Cryptococcus PCR, induced sputum, beta-D glucan |
Hairy cell leukemia, acute T-cell leukemia, T-cell lymphoma | ||
Fludarabine, ibrutinib, alemtuzumab | ||
HIV | ||
Humoural Immunodeficiency | ||
Splenectomy and asplenism | bacterial pneumonia (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae) | sputum and blood cultures, antigenuria, multiplex viral PCR |
Complement deficiency | ||
Common variable immunodeficiency | ||
Rituximab and other anti-CD20 therapy | ||
Multiple myeloma and CLL | ||
Phagocyte Defects | ||
Steroids and solid organ transplantation | systemic viruses, Aspergillus, Mycobacteria, Nocardia, Mucorales, Toxoplasma | sputum and blood cultures, antigenuria, multiplex viral PCR, CMV/HSV/VZV PCR, induced sputum, bronchoalveolar lavage, fungal culture of sputum, β-D glucan and galactomannan, Aspergillus PCR, Toxoplasma/Cryptococcus PCR |
Neutropenia | ||
Myelodysplastic syndrome | ||
Acute myelogenous leukemia | ||
Allogeneic hematopoietic stem cell transplantation |
By CT Pattern
Pattern | Differential Diagnosis | Investigations |
---|---|---|
nodular lesions | bacterial pneumonia, Aspergillus, Nocardia, Mucorales | sputum and blood cultures, antigenuria, sputum with fungal culture, Aspergillus/Mucorales PCR, galactomannan and β-D glucan, bronchoalveolar lavage |
septal thickening | atypical bacterial pneumonia | sputum and blood cultures, antigenuria, bronchoalveolar lavage |
cavitations | Mycobacteria, Histoplasma, bacterial pneumonia including Staphylococcus aureus | sputum and blood cultures, mycobacterial culture, Histoplasma PCR |
excavated nodules | bacterial pneumonia, Mucorales, Nocardia, Actinomyces, Aspergillus | sputum and blood cultures, Aspergillus/Nocardia/Mucorales PCR, galactomannan and β-D glucan |
consolidation | bacterial pneumonia, Aspergillus | sputum and blood cultures, antigenuria, sputum for fungal culture, galactomannan and β-D glucan |
pleural effusion | bacterial pneumonia, tuberculosis | sputum and blood cultures, antigenuria, mycobacterial blood culture, pleural aspiration and culture |
ground glass opacities | Pneumocystis, viral pneumonia, atypical bacterial pneumonia | sputum and blood culture, Legionella antigenuria, sputum for Pneumocystis, β-D glucan, multiplex viral PCR, CMV/VZV/HSV blood PCR, bronchoalveolar lavage |
Further Reading
- Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020;46:298-314. doi: 10.1007/s00134-019-05906-5